Antitumor mechanism of evodiamine, a constituent from Chinese herb Evodiae fructus, in human multiple-drug resistant breast cancer NCI/ADR-RES cells in vitro and in vivo

Carcinogenesis

Volumn 26, Issue 5, 2005, Pages 968-975

  Liao, Cho Hwa ^a   Pan, Shiow Lin ^a   Guh, Jih Hwa ^a   Chang, Ya Ling ^a   Pai, Hui Chen ^a   Lin, Chun Hung ^a   Teng, Che Ming ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

EVODIAMINE; PACLITAXEL; PROTEIN BCL 2; RAF PROTEIN; TUBULIN; ALKALOID; ANTINEOPLASTIC AGENT; EVODIA FRUIT; GOSYUYU; PLANT EXTRACT; QUINAZOLINE DERIVATIVE; QUINOLINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CELL CYCLE; CELL CYCLE G2 PHASE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MICROTUBULE ASSEMBLY; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TUMOR XENOGRAFT; ANIMAL; BREAST TUMOR; DRUG EFFECT; DRUG RESISTANCE; METABOLISM; MICROTUBULE; NUDE MOUSE; PHOSPHORYLATION; PHYSIOLOGY;

ALKALOIDS; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; CELL PROLIFERATION; DRUG RESISTANCE, NEOPLASM; EVODIA; FEMALE; HUMANS; MICE; MICE, NUDE; MICROTUBULES; PACLITAXEL; PHOSPHORYLATION; PLANT EXTRACTS; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-RAF; QUINAZOLINES; QUINOLINES;

EID: 19844377252     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgi041     Document Type: Article

References (35)

1. Wittmann, T., Hyman, A. and Desai, A. (2001) The spindle: a dynamic assembly of microtubule and motors. Nat. Cell. Biol., 3, E28-E34.
2. Jordan, M.A. and Wilson, L. (2004) Microtubules as a target for anticancer drugs. Nat. Rev. Cancer, 4, 253-265.
3. Drukman, S. and Kavallaris, M. (2002) Microtubule alterations and resistance to tubulin-binding agents (review). Int. J. Oncol., 21, 621-628.
4. Orr, G.A., Verdier-Pinard, P., McDaid, H. and Horwitz, S.B. (2003) Mechanisms of taxol resistance related to microtubules. Oncogene, 22, 7280-7295.
5. Bhalla, K.N. (2003) Microtubule-targeted anticancer agents and apoptosis. Oncogene, 22, 9075-9086.
6. Wang, L.G., Liu, X.M., Kreis, W. and Budman, D.R. (1999) The effect of tubulin-binding agents on signal transduction pathways of apoptosis: a review. Cancer Chemother. Pharmacol., 44, 355-361.
7. Srivastava, R.K., Mi, Q., Hardwick, J.M. and Longo, D.L. (1999) Deletion of the loop region of Bcl-2 completely blocks paclitaxel-induced apoptosis. Proc. Natl Acad. Sci. USA, 96, 3775-3780.
8. Haldar, S., Basu, A. and Croce, C.M. (1998) Serine-70 is one of the critical sites for drug-induced Bcl2 phosphorylation in cancer cells. Cancer Res., 58, 1609-1615.
9. Srivastavaa, R.K., Sasakia, C.Y., Hardwickb, J.M. and Longoa, D.L. (1999) Bcl-2-mediated drug resistance: inhibition of apoptosis by blocking nuclear factor of activated T lymphocytes (NFAT)-induced Fas ligand transcription. J. Exp. Med., 190, 253-266.
10. Haldar, S., Chintapalli, J. and Croce, C.M. (1996) Taxol induces bcl-2 phosphorylation and death of prostate cancer cells. Cancer Res., 56, 1253-1255.
11. Dhillon, A.S. and Kolch, W. (2002) Untying the regulation of the Raf-1 kinase. Arch. Biochem. Biophys., 404, 3-9.
12. Laird, A.D., Taylor, S.J., Oberst, M. and Shalloway, D. (1995) Raf-1 is activated during mitosis. J. Biol. Chem., 270, 26742-26745.
13. Ziogas, A., Lorenz, I.C., Moelling, K. and Radziwill, G. (1998) Mitotic Raf-1 is stimulated independently of Ras and is active in the cytoplasm. J. Biol. Chem., 273, 24108-24114.
14. Laird, A.D., Morrison, D.K. and Shalloway, D. (1999) Characterization of Raf-1 activation in mitosis. J. Biol. Chem., 274, 4430-4439.
15. Blagosklonny, M.V., Chuman, Y., Bergan, R.C. and Fojo, T. (1999) Mitogen-activated protein kinase pathway is dispensable for microtubule-active drug-induced Raf-1/Bcl-2 phosphorylation and apoptosis in leukemia cells. Leukemia, 13, 1028-1036.
16. Blagosklonny, M.V., Schulte, T., Nguyen, P., Trepel, J. and Neckers, L.M. (1996) Taxol-induced apoptosis and phosphorylation of Bcl-2 protein involve c-Raf-1 and represents a novel c-Raf-1 signal transduction pathway. Cancer Res., 56, 1851-1854.
17. Blagosklonny, M.V., Giannakakou, P., el-Deiry, W.S., Kingston, D.G., Higgs, P.I., Neckers, L. and Fojo, T. (1997) Raf-1/bcl-2 phosphorylation: a step from microtubule damage to cell death. Cancer Res., 57, 130-135.
18. Gottesman, M.M., Fojo, T. and Bates, S.E. (2001) Multidrug resistance in cancer: role of ATP-dependent transporters. Nat. Rev. Cancer, 2, 48-58.
19. Chiou, W.F., Sung, Y.J., Liao, J.F., Shum, A.Y. and Chen, C.F. (1997) Inhibitory effect of dehydroevodiamine and evodiamine on nitric oxide production in cultured murine macrophages. J. Nat. Prod., 60, 708-711.
20. Kobayashi, Y., Nakano, Y., Kizaki, M., Hoshikuma, K., Yokoo, Y. and Kamiya, T. (2001) Capsaicin-like anti-obese activities of evodiamine from fruits of Evodia rutaecarpa, a vanilloid receptor agonist. Planta Med., 67, 628-633.
21. Kobayashi, Y. (2003) The nociceptive and anti-nociceptive effects of evodiamine from fruits of Evodia rutaecarpa in mice. Planta Med., 69, 425-428.
22. Ogasawara, M., Matsubara, T. and Suzuki, H. (2001) Inhibitory effects of evodiamine on in vitro invasion and experimental lung metastasis of murine colon cancer cells. Biol. Pharm. Bull., 24, 917-920.
23. Ogasawara, M. and Suzuki, H. (2004) Inhibition by evodiamine of hepatocyte growth factor-induced invasion and migration of tumor cells. Biol. Pharm. Bull., 27, 578-582.
24. Liao, C.H., Pan, S.L., Guh, J.H. and Teng, C.M. (2004) Genistein inversely affects tubulin-binding agent-induced apoptosis in human breast cancer cells. Biochem. Pharmacol., 67, 2031-2038.
25. Strasser, A., O'Connor, L. and Dixit, V.M. (2000) Apoptosis signaling. Annu. Rev. Biochem., 69, 217-245.
26. Okada, H. and Mak, T.W. (2004) Pathways of apoptotic and non-apoptotic death in tumour cells. Nat. Rev. Cancer, 4, 592-603.
27. Wu, L., Smythe, A.M., Stinson, S.F., Mullendore, L.A., Monks, A., Scudiero, D.A., Paull, K.D., Koutsoukos, A.D., Rubinstein, L.V. and Boyd, M.R. (1992) Multidrug-resistant phenotype of disease-oriented panels of human tumor cell lines used for anticancer drug screening. Cancer Res., 52, 3029-3034.
28. Nieves-Neira, W. and Pommier, Y. (1999) Apoptotic response to camptothecin and 7-hydroxystaurosporine (UCN-01) in the 8 human breast cancer cell lines of the NCI anticancer drug screen: multifactorial relationships with topoisomerase I, protein kinase C, Bcl-2, p53, MDM-2 and caspase pathways. Int. J. Cancer, 82, 396-404.
29. Chadderton, A., Villeneuve, D.J., Gluck, S., Kirwan-Rhude, A.F., Gannon, B.R., Blais, D.E. and Parissenti, A.M. (2000) Role of specific apoptotic pathways in the restoration of paclitaxel-induced apoptosis by valspodar in doxorubicin-resistant MCF-7 breast cancer cells. Breast Cancer Res., 59, 231-244.
30. Stewart, Z.A., Westfall, M.D. and Pietenpol, J.A. (2003) Cell-cycle dysregulation and anticancer therapy. Trends Pharmacol. Sci., 24, 139-145.
31. Huang, Y.C., Guh, J.H. and Teng, C.M. (2004) Induction of mitotic arrest and apoptosis by evodiamine in human leukemic T-lymphocytes. Life Sci., 75, 35-49.
32. Kan, S.F., Huang, W.J., Lin, L.C. and Wang, P.S. (2004) Inhibitory effects of evodiamine on the growth of human prostate cancer cell line LNCaP. Int. J. Cancer, 110, 641-651.
33. Lovric, J. and Moelling, K. (1996) Activation of Mil/Raf protein kinases in mitotic cells. Oncogene, 12, 1109-1116.
34. Zang, M., Waelde, C.A., Xiang, X., Rana, A., Wen, R. and Luo, Z. (2001) Microtubule integrity regulates Pak leading to Ras-independent activation of Raf-1. Insights into mechanisms of Raf-1 activation. J. Biol. Chem., 276, 25157-25165.
35. Zang, M., Hayne, C. and Luo, Z. (2002) Interaction between active Pak1 and Raf-1 is necessary for phosphorylation and activation of Raf-1. J. Biol. Chem., 277, 4395-4405.